Patents by Inventor Stuart Licht

Stuart Licht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160193297
    Abstract: The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Application
    Filed: January 4, 2016
    Publication date: July 7, 2016
    Applicant: NOVARTIS AG
    Inventors: BRIAN R. BOELTCHER, SHARI LYNN CAPLAN, DOUGLAS S. DANIELS, NORIO HAMAMATSU, STUART LICHT, STEPHEN CRAIG WELDON
  • Patent number: 9368846
    Abstract: A battery and methods of forming vanadium boride nanoparticles of an anode within a battery, and a method for recharging an air battery. The battery comprises an anode and a cathode in electrochemical contact with each other through an electrically neutral ionic conductor (an electrolyte). The cathode may comprise a catalyst effective for the reduction of dissolved oxygen. An electrical discharge of the anode is performed via multiple electron oxidation of vanadium boride.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: June 14, 2016
    Assignee: The George Washington University
    Inventor: Stuart Licht
  • Patent number: 9297082
    Abstract: The present invention relates to processes for making calcium oxide electrolytically using calcium carbonate as a starting material. In a direct process, the present invention involves heating calcium carbonate to a temperature greater than its melting point or heating a molten mixture containing calcium carbonate; and subjecting the molten calcium carbonate or molten mixture to electrolysis to generate calcium oxide and oxygen, and a reduced carbon product. In an indirect process, the present invention involves heating solid calcium carbonate in a closed container to cause thermal decomposition to calcium oxide, and directing the evolved hot carbon dioxide byproduct into a molten carbonate solution, and subjecting the hot carbon dioxide molten mixture to electrolysis to generate solid carbon and oxygen, and a reduced carbon product.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: March 29, 2016
    Assignee: The George Washington University
    Inventor: Stuart Licht
  • Publication number: 20160051628
    Abstract: The invention relates to the identification of new polypeptide and protein variants of fibroblast growth factor 21 (FGF21) that have improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Application
    Filed: April 2, 2015
    Publication date: February 25, 2016
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: Brian R. BOETTCHER, Andreas LOEW, Shari L. CAPLAN, Douglas S. DANIELS, Bernhard H. GEIERSTANGER, Norio HAMAMATSU, Stuart LICHT, Stephen Craig WELDON
  • Patent number: 9266935
    Abstract: The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: February 23, 2016
    Assignee: Novartis AG
    Inventors: Brian R. Boettcher, Shari L. Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon
  • Publication number: 20160006090
    Abstract: The present disclosure relates to rechargeable electrochemical battery cells (molten air batteries). The cells use air and a molten electrolyte, are quasi-reversible (rechargeable) and have the capacity for multiple electrons stored per molecule and have high intrinsic electric energy storage capacities. The present disclosure also relates to the use of such in a range of electronic, transportation and power generation devices, such as greenhouse gas reduction applications, electric car batteries and increased capacity energy storage systems for the electric grid.
    Type: Application
    Filed: February 7, 2014
    Publication date: January 7, 2016
    Applicant: The George Washington University
    Inventor: Stuart LICHT
  • Patent number: 9080244
    Abstract: A method of producing iron by: solubilizing iron oxide as a lithiated iron oxide in a molten carbonate having lithium carbonate; and subjecting the lithiated iron oxide to electrolysis to obtain iron and oxygen. The molten alkali metal carbonate salt may further include lithium oxide. Additionally the lithium carbonate may be simultaneously subjected to electrolysis to produce steel instead of iron.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: July 14, 2015
    Assignee: The George Washington University
    Inventors: Stuart Licht, Baohui Wang
  • Publication number: 20150166622
    Abstract: The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Brian R. Boettcher, Shari L. Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon
  • Patent number: 9023791
    Abstract: The present invention provides novel polypeptide and protein variants of fibroblast growth factor 21 (FGF21) and pharmaceutical compositions comprising FGF21 polypeptide and protein variants.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: May 5, 2015
    Assignees: Novartis AG, IRM LLC
    Inventors: Brian R. Boettcher, Shari L. Caplan, Douglas S. Daniels, Bernhard H. Geierstanger, Norio Hamamatsu, Stuart Licht, Andreas Loew, Stephen Craig Weldon
  • Patent number: 9006400
    Abstract: The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: April 14, 2015
    Assignee: Novartis AG
    Inventors: Brian R. Boettcher, Shari L. Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon
  • Publication number: 20140339095
    Abstract: The present invention relates to processes for making calcium oxide electrolytically using calcium carbonate as a starting material. In a direct process, the present invention involves heating calcium carbonate to a temperature greater than its melting point or heating a molten mixture containing calcium carbonate; and subjecting the molten calcium carbonate or molten mixture to electrolysis to generate calcium oxide and oxygen, and a reduced carbon product.
    Type: Application
    Filed: November 30, 2012
    Publication date: November 20, 2014
    Inventor: Stuart Licht
  • Publication number: 20130134948
    Abstract: A battery and methods of forming vanadium boride nanoparticles of an anode within a battery, and a method for recharging an air battery. The battery comprises an anode and a cathode in electrochemical contact with each other through an electrically neutral ionic conductor (an electrolyte). The cathode may comprise a catalyst effective for the reduction of dissolved oxygen. An electrical discharge of the anode is performed via multiple electron oxidation of vanadium boride.
    Type: Application
    Filed: August 10, 2011
    Publication date: May 30, 2013
    Applicant: The George Washington University
    Inventor: Stuart Licht
  • Publication number: 20130079500
    Abstract: The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Application
    Filed: September 25, 2012
    Publication date: March 28, 2013
    Inventors: Brian R. Boettcher, Shari L. Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon
  • Publication number: 20130001072
    Abstract: A process for the production of energetically rich compounds comprising: using externally supplied thermal energy to heat an electrolyzable compound to a temperature greater than the ambient temperature; generating electricity from a solar electrical photovoltaic component; subjecting the heated electrolyzable compound to electrolysis with the solar generated electricity to generate an energetically rich electrolytic product.
    Type: Application
    Filed: September 7, 2012
    Publication date: January 3, 2013
    Applicant: The George Washington University
    Inventor: Stuart LICHT
  • Publication number: 20120129766
    Abstract: The invention relates to the identification of new polypeptide and protein variants of fibroblast growth factor 21 (FGF21) that have improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
    Type: Application
    Filed: November 15, 2011
    Publication date: May 24, 2012
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: Brian R. BOETTCHER, Shari L. CAPLAN, Douglas S. DANIELS, Bernhard H. GEIERSTANGER, Norio HAMAMATSU, Stuart LICHT, Andreas LOEW, Stephen Craig WELDON
  • Publication number: 20100200418
    Abstract: A process for the production of energetically rich compounds comprising: using externally supplied thermal energy to heat an electrolyzable compound to a temperature greater than the ambient temperature; generating electricity from a solar electrical photovoltaic component; subjecting the heated electrolyzable compound to electrolysis with the solar generated electricity to generate an energetically rich electrolytic product.
    Type: Application
    Filed: February 12, 2010
    Publication date: August 12, 2010
    Applicant: THE GEORGE WASHINGTON UNIVERSITY
    Inventor: Stuart Licht
  • Publication number: 20080261094
    Abstract: Stabilized electrodes for electrochemical cells. An electrochemical cell based on an environmentally benign zirconia stabilized Fe6+/B2? chemistry is disclosed. An electrochemical potential is sustained compatible to the pervasive, conventional alkaline (MnO2—Zn battery), and with a much higher electrical storage capacity. Either or both the anode and cathode may be stabilized. For example, a zirconia overlayer on either TiB2 or VB2 boride anodes, and/or super-iron, K2FeO4, cathodes stabilizes the electrodes, while sustaining facile charge transfer. The energetic Fe6+ cathode elevates, and fully compensates for, the boride/zinc anode potential differential.
    Type: Application
    Filed: April 20, 2007
    Publication date: October 23, 2008
    Inventors: Stuart Licht, Xingwen Yu
  • Publication number: 20070119717
    Abstract: The invention relates to a novel preparation of Fe(VI) salts, also known as Super-iron or ferrates, based on direct electrolytic synthesis into the solid-phase. According to the invention there are two half-cells which are in an electrochemical contact with one another through an electrically neutral ionic conductor, wherein one of said half-cells comprises a cathode and the other half cell comprises at least 1% by weight of an iron containing material, wherein a power supply is used to oxidize the iron containing material to a solid Fe(VI) salt.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 31, 2007
    Applicant: CHEMERGY LTD.
    Inventor: Stuart Licht
  • Publication number: 20060194107
    Abstract: An electric storage alkaline battery comprising an electrically neutral alkaline ionic conductor, an anode and a cathode, whereby electric storage is accomplished via electrochemical reduction of the cathode and oxidation of the anode, whereby said cathode includes electrochemically active silver (per)manganate materials.
    Type: Application
    Filed: September 12, 2005
    Publication date: August 31, 2006
    Applicant: Chemergy, Energy Technologies
    Inventor: Stuart Licht
  • Publication number: 20030211395
    Abstract: An electric storage alkaline battery comprising an electrically neutral alkaline ionic conductor, an anode and a cathode, whereby electric storage is accomplished via electrochemical reduction of the cathode and oxidation of the anode. The cathode contains a known alkaline cathode material such as either MnO2, NiOOH, AgO or HgO and an amount of at least 1% of a fluorinated, polymer graphite, and wherein the cathode has a discharge capacity greater than the conventional cathode storage capacity of the known cathode material.
    Type: Application
    Filed: November 1, 2002
    Publication date: November 13, 2003
    Inventor: Stuart Licht